Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,254 across all filing types
Latest filing 2012-02-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
北京市国枫律师事务所关于公司申请首次公开发行股票并在创业板上市的补充法律意见之二
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandfield Law Offices regarding the application of Changsha Sinocare Biosensor Technology Co., Ltd. for its initial public offering (IPO) and listing on the ChiNext board. It includes detailed legal opinions, verification of the issuer's qualifications, financial audit references, business and asset descriptions, shareholder information, and compliance with relevant laws and regulations. The document references an audit report but is itself a legal opinion related to the IPO process, not a financial report or earnings release. It is not a report publication announcement since it contains substantive legal analysis and opinions. The document is a standalone legal opinion related to the IPO process, which fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories like Annual Report, Audit Report, or Capital/Financing Update. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2012-02-23 Chinese
北京市国枫律师事务所关于公司申请首次公开发行股票并在创业板上市的补充法律意见之七
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandfield Law Offices regarding the application for initial public offering (IPO) and listing on the Growth Enterprise Market (创业板) by Changsha Sinocare Biosensor Technology Co., Ltd. It is titled as a "Supplementary Legal Opinion No. 7" and discusses legal compliance, amendments to the company's articles of association, dividend policy, and shareholder return plans related to the IPO process. The document is a legal advisory and opinion related to the IPO process, not a financial report, earnings release, or management discussion. It is not an announcement of voting results or a proxy solicitation. It is a legal opinion letter supporting the IPO application and listing process. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and legal opinion related to the IPO filing process, not a financial report or other specific category.
2012-02-23 Chinese
第一届董事会第九次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the first board meeting of Changsha Sinocare Biosensor Technology Co., Ltd. It details decisions made by the board, including approval of financial reports for 2009, 2010, and 2011, internal control self-evaluation, and matters related to the company's initial public offering and listing on the Growth Enterprise Market. The document is a formal record of board decisions rather than the financial reports themselves or an announcement of voting results to shareholders. It does not contain financial statements or detailed financial data but rather the board's resolutions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2012-02-23 Chinese
内部控制鉴证报告（2011年12月31日）
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制鉴证报告" which translates to "Internal Control Assurance Report." It is issued by an accounting firm (ShineWing) and addresses the internal control effectiveness related to the financial report as of December 31, 2011. The content includes detailed descriptions of the company's internal control environment, governance, risk management, and self-evaluation of internal control effectiveness. It is a standalone report focused on internal control assurance rather than a full annual report or financial statement. The document is not a brief announcement or a certification letter but a substantive assurance report on internal controls. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control assessments. Therefore, the appropriate classification is AR with high confidence. FY 2011
2012-02-23 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.